Colgate-Palmolive Company

🇺🇸New York Stock Exchange
Back to all articles
Colgate-Palmolive Company stock analysis CL overview
Somewhat Bearish -25

Colgate-Palmolive: Too Expensive For A Defensive Firm

📉 Colgate-Palmolive (CL) delivered 8% sales growth in Q1 2026, but earnings per share declined by 6%.

👎 Analysts have downgraded the stock to a "conservative hold" rating due to mixed performance.

📈 Organic revenue growth is estimated at just 2.9%, below total sales growth metrics.

🧴 North America sales are declining, driven by increased toothpaste competition and margin compression.

🌍 Foreign exchange (FX) tailwinds provided significant growth in Latin America, EMEA, and APAC regions.

⚠️ There is concern that the recent international growth may not be sustainable if currency trends reverse.

💸 Low U.S. consumer confidence and elevated input costs are creating near-term headwinds for the company.

🛢️ A specific $300 million impact from the Middle East is contributing to current cost pressures.

⚖️ The disconnect between strong top-line sales and weaker earnings suggests underlying profitability issues.

📊 Currency fluctuations in international markets are temporarily masking structural weakness in North American operations.

Bullish Signals
  • Colgate-Palmolive delivered 8% sales growth in the first quarter of 2026, demonstrating resilient topline performance.
  • Foreign exchange tailwinds provided a significant boost to growth across Latin America, EMEA, and APAC regions.
Risk Factors
  • Despite an 8% total sales growth in Q1 2026, EPS declined by 6%, prompting a conservative hold rating due to underlying profitability concerns.
  • Organic growth is estimated at only 2.9%, indicating that headline sales figures are largely driven by external factors rather than core business performance.
  • North America sales are specifically falling due to increased toothpaste competition, which threatens the company's dominant domestic market position.
  • Margin compression in key markets reduces profitability even as top-line numbers appear healthy.
  • Significant growth in Latin America, EMEA, and APAC regions is driven by FX tailwinds, creating a risk that earnings will reverse if currency trends fluctuate.
  • Persistent low U.S. consumer confidence creates a macroeconomic headwind that could dampen demand for discretionary or semi-discretionary personal care products.
  • Elevated input costs pose a continued pressure on margins and pricing power.
Full Analysis
Colgate-Palmolive (CL) reported first quarter 2026 earnings with total sales up 8%, though this figure masks organic growth of just 2.9%. The company's earnings per share (EPS) actually declined by 6% during the period. A key driver for the headline sales growth was foreign exchange tailwinds, particularly in Latin America, Europe, the Middle East, and Africa regions, but the article notes these gains raise concerns about long-term sustainability should currency trends reverse. In the North American market, revenue fell due to intensifying competition in the toothpaste sector and associated margin compression. Beyond domestic issues, the company faces persistent low U.S. consumer confidence and elevated input costs, including a specific $300 million impact from events in the Middle East that are expected to create near-term headwinds for performance. The author concludes with a conservative "hold" rating on the stock, arguing that while the topline growth appears attractive initially, the combination of weak organic growth, regional vulnerabilities, and cost pressures suggests the current valuation is too expensive for a defensive firm like Colgate-Palmolive. The analysis emphasizes that without organic improvement and currency stability, the stock's risk profile remains elevated despite recent sales figures.